ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1775

The Phosphoinositide 3-Kinase Pathway Regulates Fibroblast-Like Synoviocyte Invasion

Beatrix Bartok1, Deepa Hammaker2 and Gary S. Firestein3, 1Rheumatology, UCSD, La Jolla, CA, 2MC 0656, Univ of California San Diego, La Jolla, CA, 3Div of Rheumatology, UCSD School of Medicine, La Jolla, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines, Fibroblasts, rheumatoid arthritis (RA) and signal transduction

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Cartilage destruction mediated by invasive fibroblast-like synoviocytes (FLS) plays a central role in pathogenesis of RA. Increased cell migration and degradation of extracellular matrix are fundamental to these processes. The Class I phosphoinositide 3-kinases (PI3K) control cell survival, proliferation and migration, which might be involved with cartilage damage in RA. PI3Kdelta isoform expression was recently identified as a key regulator of FLS growth and survival, suggesting that it could contribute to synoviocyte aggressive behavior. Therefore, we assessed the role of PI3Kdelta in synoviocyte invasion and matrix degradation using isoform selective PI3K inhibitors. 

Methods: FLS were cultured in Matrigel coated transwells. PI3K inhibitors or vehicle were added to the upper chamber and PDGF was used as a chemoattractant in the lower chamber. The invading cells were quantified by staining the filters with 1% crystal violet. F-actin was visualized with Rhodamin phalloidin and analyzed with fluorescent microscopy. Rac1 activation was measured using PAK1/PBD GST pull down and quantified by Western blot analysis. PI3K inhibitors included: pan (GDC-0941), PI3Kalpha (A66), PI3Kbeta (TGX-221), PI3Kgamma (AS-252424), PI3Kdelta (INK007 and CAL-101) and PI3K-delta/gamma (INK055 and IPI-145).

Results: PDGF-directed invasion was completely inhibited by the pan PI3K inhibitor (1 uM). To define the role of the individual isoforms, we tested the effect of the isoform selective PI3K inhibitors. PI3Kdelta inhibition (INK007) significantly decreased the number of invading cells, with 60±5% inhibition at 1 uM (p< 0.04). Similar results were observed with two other inhibitors with distinct chemical structures (CAL-101 and INK055). The PI3Kalpha inhibitor decreased invasion by 40±5% while PI3Kbeta and PI3Kgamma inhibitors had no effect. Phalloidin staining was then used to visualize FLS actin rearrangement in response to PDGF with or without PI3K inhibitors. PI3Kdelta inhibition by INK007, CAL-101 and IPI-145 decreased lamellipodia formation by 50±6% (p<0.05). Similar inhibition was seen with the pan PI3K inhibitor, while the selective inhibitors of PI3Kalpha, PI3Kbeta or PI3Kgamma had no effect. We then hypothesized that PI3Kdelta might modulate activation of Rho GTPases in synoviocytes, which regulate actin organization. PI3Kdelta inhibition with INK007 had no effect on baseline Rac1 activation but blocked activation in response to PDGF by 95±6% (p<0.03). Similar findings were observed with the pan PI3K inhibitor, while PI3Kalpha inhibition had no significant effect. 

Conclusion: PI3Kdelta is a major regulator of FLS migration and invasion and functions by inhibiting Rac1 activation and modulating F actin cytoskeleton rearrangement. These observations, together with previous findings that PI3Kdelta regulates FLS growth and survival, suggest that PI3Kdelta inhibition could be chondroprotective in RA by modulating synoviocyte growth, migration and invasion.


Disclosure:

B. Bartok,
None;

D. Hammaker,
None;

G. S. Firestein,

Infinity Pharmaceuticals,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-phosphoinositide-3-kinase-pathway-regulates-fibroblast-like-synoviocyte-invasion/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology